About 1 result found for searched term "1629760-28-6" (0.133 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24755 | Ladiratuzumab | Others |
| hLIV22 | ||
| Ladiratuzumab (hLIV22) is an anti-LIV-1/ZIP6 humanized monoclonal antibody. Ladiratuzumab, conjugated with the microtubule disrupting agent, MMAE to compose SGN-LIV1A, an antibody-drug conjugate (ADC). Ladiratuzumab can be used for research of breast cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
